Skip to content
healthcare.dev

TOFACITINIB CITRATE

NDC 0574-1811, Tofacitinib Citrate, tablet, film coated, extended release, from Padagis US LLC.

Product NDC
0574-1811
Status
Listed
Labeler
Padagis US LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0574-1811 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE11 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0574-1811-300057418113030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0574-1811-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/df24e90d-4b2c-4f9d-a1d6-fcb1ab00606f
  • NADAC price for package 00574181130

    GET /v1/drugs/nadac/00574181130

Use it

Look up 0574-1811 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0574-1811 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0574-1811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.